ArticleJournal of general internal medicine2026
Receipt of Pharmacotherapy and Association with Healthcare Utilization Among US Adults with Alcohol or Opioid Use Disorder, 2022-2023.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundEvery year, millions of US adults with substance use disorders (SUDs) interface with the healthcare system, with high rates of emergency department (ED) visits and hospitalizations. FDA-approved medications for alcohol (AUD) and opioid use disorder (OUD) have been shown to decrease acute care utilization for addiction-related issues. However, the characteristics of adults who receive these medications and how receipt is associated with healthcare utilization are not well understood. The objective of this study was to characterize US adults with AUD or OUD who received addiction pharmacotherapy and to examine the association between pharmacotherapy receipt and healthcare utilization in a nationally representative cross-sectional sample.
methodsUsing data from the National Survey of Drug Use and Health 2022-2023, we included US adults with AUD or OUD and tested the association between self-reported receipt of pharmacotherapy for SUD and healthcare utilization (ED visits, nights hospitalized, and outpatient visits) using negative binomial regression models adjusted for sociodemographic covariates and medical comorbidities. OUTCOMES: Among US adults with AUD and/or OUD, only 4.8% reported use of medication for addiction treatment in the past 12 months. In adjusted models, receiving pharmacotherapy for substance use was associated with increased number of times treated in the ED (IRR 1.57; 95% CI 1.16, 2.14) increased number of nights hospitalized (IRR 2.79; 95% CI 1.10, 4.87) and increased number of outpatient visits (IRR 1.28; 95% CI 1.02, 1.60).
conclusionIn this nationally representative sample of adults with substance use disorder, few reported receipt of pharmacotherapy for SUD in the past year. Individuals receiving MAUD or MOUD reported higher rates of healthcare utilization. The findings underscore the need to identify best practices in outpatient settings to screen and initiate treatment for individuals with substance use disorders, ideally prior to decompensation requiring a higher level of care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.